Ortivus

Ortivus ROCE

The Return on Capital Employed (ROCE) of Ortivus (ORTI B.ST) as of Nov 19, 2026 is -88.36 %. In the previous year, Return on Capital Employed (ROCE) was 296.18 % — a change of -129.83% (lower).

ROCE

-88.36 %

YoY

-129.83%

Last updated:

In 2025, Ortivus's return on capital employed (ROCE) was -88.36 %, a -129.83% increase from the 296.18 % ROCE in the previous year.

The Ortivus ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2018
-593.44 SEK
Jan 1, 2019
-176.71 SEK
Jan 1, 2020
57.89 SEK
Jan 1, 2021
31.74 SEK
Jan 1, 2022
16.50 SEK
Jan 1, 2023
-103.94 SEK
Jan 1, 2024
296.18 SEK
Jan 1, 2025
-88.36 SEK
The Ortivus ROCE history
YEARROCEYoY
-88.36 %-129.83%
296.18 %-384.95%
-103.94 %-729.92%
16.50 %-48.02%
31.74 %-45.17%
57.89 %-132.76%
-176.71 %-70.22%
-593.44 %+783.52%
-67.17 %-31.39%
-97.89 %+118.58%
-44.79 %-619.48%
8.62 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ortivus Stock analysis

What does Ortivus do? Ortivus AB develops and sells clinical devices and systems, including MobiMed Smart, a decision support system for ambulance personnel to handle documentation, monitoring, and structured prehospital care. CoroNet is a mobile surveillance solution enabling patients to move freely under medical supervision while providing healthcare professionals with real-time monitoring data. The company offers additional services like support, implementation, training, and consulting. Its primary customers are ambulance services and emergency departments. Ortivus AB generates revenue through the sale of MobiMed Smart and CoroNet systems, along with associated services. Ambulance services and emergency departments purchase these products to improve prehospital care documentation and patient monitoring. The decision support system MobiMed Smart streamlines ambulance operations, while CoroNet enhances patient supervision in healthcare settings, addressing key needs for efficient medical response and care management. The company's revenue model relies on direct sales of its clinical systems and supplementary services to healthcare providers. MobiMed Smart targets ambulance personnel for prehospital care documentation, and CoroNet serves healthcare professionals needing mobile patient monitoring. These products are tailored to the specific operational requirements of ambulance services and emergency departments, ensuring alignment with their workflows and care standards. Ortivus is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Ortivus's Return on Capital Employed (ROCE)

Ortivus's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Ortivus's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Ortivus's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Ortivus’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Ortivus stock

Return on Capital Employed (ROCE) of Ortivus is -88.36 % in 2025.

Return on Capital Employed (ROCE) of Ortivus changed from 296.18 % to -88.36 %, representing a -129.83% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Ortivus since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Ortivus with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Ortivus

All Key Metrics — Ortivus